Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind active-controlled study of HB002.1M in wet age-related macular degeneration
CTR20200948Phase 2Active
- Sponsor
- Huabo Biopharm
- Start
- Jun 2020
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of HB002.1M, sponsored by Huabo Biopharm. Started Jun 2020; status: active.
02
Drugs
HB002.1M
Beyond the preview
Go deeper on CTR20200948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200948.